Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01518270 · ClinicalTrials.gov registry record
Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 179
- Enrollment target
NCT01518270: Completed study, sponsored by Allergan.
NCT01518270 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 179 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01518270 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 179 participants
- Enrollment target
Study Summary
This study will asses epidemiologic changes in eyelash characteristics with increasing age.
Primary Outcome
Photographs were taken of the eyelashes. Length was measured in millimeters. Data from both eyes were averaged for each participant for analysis.
Interventions
- OTHER No treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2011-12-01 |
| Est. Completion | 2011-12-16 |
What the finished NCT01518270 record still lists
NCT01518270 is an observational study that tracks outcomes without assigning an intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No treatment is the first listed.
NCT01518270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01518270 about?
NCT01518270 is a clinical study titled "Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women". This study will asses epidemiologic changes in eyelash characteristics with increasing age.
What is the current status of trial NCT01518270?
This trial is currently completed. The enrollment target is 179 participants. The study started on 2011-12-01. Estimated completion is 2011-12-16.
What interventions are being tested in trial NCT01518270?
The interventions under investigation include: No treatment (OTHER).
Who is sponsoring clinical trial NCT01518270?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI